Latest La Jolla Institute Stories
MAINZ, Germany, April 22, 2015 /PRNewswire/ -- Potential for truly personalized treatment of any cancer BioNTech AG [http://www.biontech.de
A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design.
A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today.
Most people probably know that heart disease remains the nation's No. 1 killer.
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs.
Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
A war is being waged in the pancreases of millions of people throughout the world.
Researchers at the La Jolla Institute for Allergy & Immunology have identified a previously unknown mechanism that generates protective immune memory cells to fight recurring infections at the body's mucosal linings – which include the mouth, the intestines, the lungs and other areas.
- A young chicken: also used as a pet name for children.